GeneReach Biotechnology Corp.(TW:4171)
NT$15.50+0.05 (+0.32%)
TW:4171
GeneReach Biotechnology Corp. Revenue
NT$15.50
At close:+0.05 (+0.32%)
GeneReach Biotechnology Corp. (4171) Revenue
GeneReach Biotechnology Corp. Revenue
GeneReach Biotechnology Corp. had a revenue of 60.02M in the quarter ending Jun 30, 2026, with 14.81%. This bring the company's revenue in the last twelve months to 238.08M, Increased 2.38%. In the fiscal year ending Dec 31, 2025, GeneReach Biotechnology Corp. had annual revenue of 232.74M with 12.71% growth.
- Revenue (ttm)
- 238.08M
- Revenue Growth
- 11.99%
- P/S Ratio
- 3.85
- Revenue/Employee
- TWD 1,939,508
- Employees
- 120
- Market Cap
- TWD 896.99M
Revenue Chart
GeneReach Biotechnology Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 232.74M | 26.25M | 12.71% |
| Dec 31, 2024 | 206.49M | -18.97M | -8.41% |
| Dec 31, 2023 | 225.46M | -524.56M | -69.94% |
| Dec 31, 2022 | 750.02M | -262.06M | -25.89% |
| Dec 31, 2021 | 1.01B | 155.04M | 18.09% |
| Dec 31, 2020 | 857.03M | 491.24M | 134.29% |
| Dec 31, 2019 | 365.80M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.